Median Diagnostics Inc. (XKON:233250)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,990
-500 (-4.35%)
At close: Dec 15, 2025
-31.31%
Market Cap20.07B
Revenue (ttm)7.86B
Net Income (ttm)-567.58M
Shares Out1.75M
EPS (ttm)-496.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume16
Average Volume3
Open11,490
Previous Close11,490
Day's Range10,000 - 11,490
52-Week Range10,190 - 16,600
Beta0.15
RSI47.94
Earnings Daten/a

About Median Diagnostics

Median Diagnostics Inc. manufactures and sells veterinary medicines and diagnostic reagents. The company’s products include PCR sets for pigs, ruminants, poultry, equine, canine and feline, and shrimps; rapid kits for pigs, ruminants, poultry, canine, feline, erwinia amylovora, and bovine pregnancy; ELISA for pigs, ruminants, avians, and horses; standard reagents, including AGID, HI, and FA; and antigen/antibody, including antibodies for veterinary diagnostics, and antibodies and antigens for human diagnostics. It also offers mouse and rat path... [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1999
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 233250
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.